Finance

Beta
Lists
524606:BOM
Beryl Drugs Ltd
₹22.84
+6.98%
(+1.49) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524606...
Open
₹21.78
High
₹22.84
Low
₹21.77
Mkt. cap
115.84M
Avg. vol.
1.30K
Volume
6.04K
P/E ratio
755.79
52-wk high
₹30.00
52-wk low
₹15.92
EPS
₹0.03
Open
₹21.78
High
₹22.84
Low
₹21.77
Mkt. cap
115.84M
Avg. vol.
1.30K
Volume
6.04K
P/E ratio
755.79
52-wk high
₹30.00
52-wk low
₹15.92
EPS
₹0.03
News stories
From sources across the web
About Beryl Drugs Ltd
CEO-
Employees-
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
47.94M
51.20M
37.77M
54.67M
Cost of goods sold
20.25M
25.81M
20.37M
31.23M
Cost of revenue
20.25M
25.81M
20.37M
31.23M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.34M
5.77M
7.89M
6.29M
Operating expense
25.98M
21.98M
22.56M
14.07M
Total operating expenses
46.24M
47.80M
42.93M
45.30M
Operating income
1.71M
3.40M
-5.16M
9.37M
Other non operating income
-
-
-
-
EBT including unusual items
697.00K
2.60M
-6.08M
8.66M
EBT excluding unusual items
697.00K
2.60M
-6.08M
8.66M
Income tax expense
486.00K
2.51M
-4.40M
3.03M
Effective tax rate
69.73%
96.58%
72.41%
35.03%
Other operating expenses
16.84M
12.30M
11.49M
3.75M
Net income
211.00K
89.00K
-1.68M
5.62M
Net profit margin
0.44%
0.17%
-4.44%
10.29%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.01M
-802.00K
-917.00K
-715.00K
Net interest expenses
-1.01M
-802.00K
-917.00K
-715.00K
Depreciation and amortization charges
3.81M
3.92M
3.18M
4.03M
EBITDA
4.82M
7.27M
-2.05M
13.11M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more